How to influence health providers

被引:1
作者
Axon, Anthony [1 ]
机构
[1] Gen Infirm, Dept Gastroenterol, Leeds LS1 3EX, W Yorkshire, England
关键词
gastric cancer; health inequality; health economics; media; health providers;
D O I
10.1111/j.1523-5378.2007.00569.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In spite of the recognition that Helicobacter pylori is responsible for most duodenal ulcer and peptic ulcer and that it is the underlying cause of most gastric cancer, little or no attention has been paid to its effect upon public health and in particular no measures have been put in place to address them. For over 20 years relatively inexpensive and noninvasive testing and treatment have been available, but no country has introduced a '' screen-and-treat '' policy, and relatively little research has been devoted to the identification of a vaccine for the disease. Health-care providers and doctors themselves are amenable to persuasion but in order to achieve appropriate investment in this area media pressure is required to publicize the arguments of health economics and equality of health that support the introduction of appropriate measures. There is a strong movement to eradicate inequalities of health. Population studies have shown that eradication of the infection can be provided at reasonable cost. Such a policy can easily be audited. Helicobacter pylori infection is the commonest environmental cause of cancer death after smoking, the diseases it causes represent a serious cost to health providers, and it affects the poorest members of our society. In the words of Kofi Annan, '' Health should not be regarded as a blessing to be wished for, but a human right to be fought for ''.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 14 条
[1]   Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection [J].
Ekström, AM ;
Held, M ;
Hansson, L ;
Engstrand, L ;
Nyrén, O .
GASTROENTEROLOGY, 2001, 121 (04) :784-791
[2]   A community screening program for Helicobacter pylori saves money:: 10-year follow-up of a randomized controlled trial [J].
Ford, AC ;
Forman, D ;
Bailey, AG ;
Axon, ATR ;
Moayyedi, P .
GASTROENTEROLOGY, 2005, 129 (06) :1910-1917
[3]  
Honda S, 1998, CANCER RES, V58, P4255
[4]  
*IARC, 1994, MON EV CARC RISK HUM, V61
[5]   Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils:: effects of bacteria eradication [J].
Keto, Y ;
Ebata, M ;
Okabe, S .
JOURNAL OF PHYSIOLOGY-PARIS, 2001, 95 (1-6) :429-436
[6]  
KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO
[7]  
2-4
[8]   Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project:: randomised controlled trial [J].
Lane, JA ;
Murray, LJ ;
Noble, S ;
Egger, M ;
Harvey, IM ;
Donovan, JL ;
Nair, P ;
Harvey, RF .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7535) :199-202
[9]  
MARSHALL BJ, 1984, LANCET, V1, P1311
[10]   The cost-effectiveness of population Helicobacter pylori screening and treatment:: a Markov model using economic data from a randomized controlled trial [J].
Mason, J ;
Axon, ATR ;
Forman, D ;
Duffett, S ;
Drummond, M ;
Crocombe, W ;
Feltbower, R ;
Mason, S ;
Brown, J ;
Moayyedi, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) :559-568